MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer
| Autor: | Anne Kallioniemi, Kimmo Savinainen, Reija Autio, Riina Kuuselo, Saana Sandström |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Cancer Research
Cell division Blotting Western Biology Article Immunoenzyme Techniques Cell Movement Cell Line Tumor Pancreatic cancer Gene expression Biomarkers Tumor Cell Adhesion medicine Humans Gene silencing Genes Tumor Suppressor RNA Messenger RNA Small Interfering Cell Proliferation Oligonucleotide Array Sequence Analysis Mediator Complex Oncogene Reverse Transcriptase Polymerase Chain Reaction Cell growth Gene Expression Profiling Oncogenes Cell cycle medicine.disease Pancreatic Neoplasms Survival Rate Oncology Cancer cell Cancer research |
| Zdroj: | International Journal of Cancer. 129:2553-2565 |
| ISSN: | 0020-7136 |
| Popis: | Mediator complex subunit 29 (MED29) is part of a large multiprotein coactivator complex that mediates regulatory signals from gene-specific activators to general transcription machinery in RNA polymerase II mediated transcription. We previously found that MED29 is amplified and overexpressed in pancreatic cancer and that MED29 silencing leads to decreased cell survival in PANC-1 pancreatic cancer cells with high MED29 expression. Here we further demonstrate decreased migration, invasion and colony formation in PANC-1 cells after MED29 silencing. Unexpectedly, lentiviral-based overexpression of MED29 led to decreased proliferation of NIH/3T3 cells as well as MIAPaCa-2 pancreatic cancer cells with low endogenous expression. More importantly, subcutaneous inoculation of the MED29-transduced pancreatic cancer cells into immuno-compromised mice resulted in dramatic tumor suppression. The mock-control mice developed large tumors, whereas the animals with MED29-xenografts showed both decreased tumor incidence and a major reduction in tumor size. Gene expression analysis in the MED29-transduced pancreatic cancer cells revealed differential expression of genes involved in control of cell cycle and cell division. The observed gene expression changes are expected to modulate the cell cycle in a way that leads to reduced cell growth, explaining the in vivo tumor suppressive phenotype. Taken together, these data implicate MED29 as an important regulator of key cellular functions in pancreatic cancer with both oncogenic and tumor suppressive characteristics. Such a dualistic role appears to be more common than previously thought and is likely to depend on the genetic background of the cancer cells and their surrounding environment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text